Rchr
J-GLOBAL ID:201901011071873398   Update date: May. 24, 2021

Isono Makoto

Isono Makoto
Affiliation and department:
Other affiliations (1):
  • 札幌医科大学病理学第一講座  訪問研究員
Research field  (1): Urology
Research theme for competitive and other funds  (2):
  • 2019 - 2022 DNA修復経路に着目した、シスプラチン耐性の膀胱癌に対する新たな治療法の開発
  • 2014 - 2015 進行腎癌に対する新規治療の開発
Papers (37):
more...
MISC (86):
Lectures and oral presentations  (9):
  • The ataxia telangiectasia and Rad3-related kinase inhibitor AZD6738 overcomes cisplatin resistance in long-term cisplatin treated bladder cancer cells.
    (The 34th Annual Congress of European Association of Urology 2019)
  • The ataxia telangiectasia and Rad3-related kinase inhibitor AZD6738 sensitizes bladder cancer cells to gemcitabine.
    (The 33rd Annual Congress of European Association of Urology 2018)
  • Phenoxodiol, a novel soy isoflavone analog, inhibits Akt pathway and induces renal cancer apoptosis.
    (The 112nd American Urological Association Annual Meeting 2017)
  • The novel checkpoint kinase 1 inhibitor MK-8776 strongly sensitizes bladder cancer cells to gemcitabine.
    (The 32st Annual Congress of European Association of Urology 2017)
  • Ritonavir and delanzomib inhibit renal cancer growth in vitro and in vivo by inducing endoplasmic reticulum stress synergistically.
    (The 111st American Urological Association Annual Meeting 2016)
more...
Professional career (1):
  • 博士(医学) (防衛医科大学校)
Work history (9):
  • 2019 - 現在 恵佑会札幌病院 泌尿器科
  • 2018 - 現在 Sapporo Medical University
  • 2017 - 2019 陸上自衛隊第11旅団司令部 医務官室 医務官
  • 2013 - 2017 防衛医科大学校 泌尿器科学講座 研究科学生
  • 2015 - 2016 Heinrich Heine大学 泌尿器科学講座 客員研究員
Show all
Association Membership(s) (5):
JAPAN SOCIETY FOR REPRODUCTIVE MEDICINE ,  Japanese Society for Dialysis Therapy ,  THE JAPANESE CANCER ASSOCIATION ,  JAPANESE SOCIETY OF ENDOUROLOGY ,  THE JAPANESE UROLOGICAL ASSOCIATION
※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page